horses. In the rabbit, multiple doses of as low as 10 ,4g resulted in the production of serum capable of inducing long-chain formation and opsonizing and mouse protective antibody. Two doses of 100 ,ug elicited similar responses. The bactericidal capacity of this serum could be eliminated by absorption with whole S. equi cells or their extracts, but not by absorption with trypsin-treated cells or extracts therefrom. Horses vaccinated 15 months previously with a whole-cell killed vaccine and given 200 jig of the purified protein intramuscularly showed evidence of an anamnestic response to the antigen.
The M protein component of group A streptococci has been shown to be an effective antigen in evoking protective antibodies in both experimental animals and in humans (11) . Extensive purification of the M protein has been necessary in order to prepare a product suitable for human use (6) . Although such purification is not mandatory for animal administration, evaluation of a product which has potential use in humans must first be carried out in laboratory animals. Similar evaluation precedes the introduction of a new veterinary vaccine. Such a product is warranted in the case of vaccination against the equine equivalent of human streptococcal sore throat, namely strangles, the etiological agent of which is a Lancefield group C streptococcus, Streptococcus equi. Present vaccines prepared from this organism consist of freeze-dried, unwashed broth cultures inactivated after a few hours of logarithmic-phase growth and are administered in a series of three large injections. Although the vaccine is effective in conferring protection, the nature of the immunizing antigen(s) has not been defined. The work to be described here was designed to identify such an antigen(s) as a prelude to the possible development of an altemative vaccine against upper respiratory tract infection in horses caused by S. equi.
MATERIALS AND METHODS
Organism. A strain of S. equi was obtained from A. Gulasekharem, Commonwealth Serum Laboratories, Melbourne, Australia. This strain had been isolated from the exudate of a ruptured submaxillary lymph node of a horse affected with strangles. The organism had been freeze-dried after a minimal number of subcultures from the original plate.
M-like protein purification. S. equi was grown in Todd-Hewitt broth (Oxoid), supplemented with 8 g of glucose/liter. A 900-ml culture was used to inoculate 8 liters of broth, which was incubated for 24 h.
The first stage of purification involved hot acid extraction, acid concentration, and ammonium sulfate fractionation (12) . The cells from the batch culture were collected by centrifugation. The difficulty in obtaining a packed sediment meant that repeated washings were necessary. Two washings with normal saline were followed by a distilled water wash and two further washings in phosphate-buffered saline, pH 7 .0. The washed cells were finally resuspended in 100 ml of saline, the pH was adjusted to 2.4 with 1 N HCl, and the suspension was heated to 95 C in a boiling water bath for 12 min. After cooling, the suspension was neutralized with 1 N NaOH and centrifuged. The supernatant fluid was removed, the bacterial sediment was resuspended in 50 ml of saline, and the extraction procedure was repeated.
The combined supernatants were next treated with 6 N HCl, giving a flocculent precipitate at pH 2.0. . Digestion with the enzyme continued for 5 h at 37 C, followed by further dialysis overnight at 4 C. Ammonium sulfate fractionation of the dialyzed fluid was performed at 4 C. The solution was brought to 30% saturation and then centrifuged. The resulting supernatant was then brought to 60% saturation, and the solution was mechanically stirred for 30 min at 4 C. The pellet obtained after centrifugation was solubilized in 10 ml of distilled water and dialyzed against phosphate-buffered saline for 18 h at 4 C and then freeze-dried.
The next stage of purification utilized column chromatography, in which carboxymethylcellulose with acidic elution was used (15) . Twenty milligrams of partially purified antigen was dissolved in 50 ml of 0.05 M sodium acetate buffer, pH 4.5, and slowly adsorbed onto a column (1 by 11 cm) of carboxymethylcellulose equilibrated with the same buffer. Acidic elution was performed with 0.02 M HCl after a previous elution with sodium acetate buffer. Chromatography was carried out at room temperature. Fractions of approximately 3 ml were collected, and protein peaks were monitored at 280 nm. Tubes containing material which produced readings at this wavelength were adjusted to bring the pH to approximately 7.4 and the salinity to 0.15 M. These fractions were then tested for their serological reactivity by immunodiffusion. Samples giving a positive reaction with S. equi antiserum were pooled and concentrated with polyethylene glycol. Protein concentration was determined by the biuret reaction, using crystalline bovine serum albumin as the standard.
Preparation of vaccine. The preparation was an alum-precipitated one (7) . Protein solution (8 ml) in normal saline was added to 3 ml of 0.2 M aluminum potassium sulfate. Drops of 1 M sodium hydroxide were used to adjust the pH of the solution to 6.0, and, at this point, 1.5 ml of 0.1 M sodium acetate, pH 7.0, was added. The pH of this solution was again adjusted with sodium hydroxide, and the mixture was incubated at 37 C for 1 h followed by chilling at 4 C for an additional hour. The aluminum hydroxide was separated by centrifugation, washed twice with cold sterile Ringer lactate buffer, and then suspended in this buffer. After addition of merthiolate, this preparation was now ready for injection.
A similar vaccine was prepared, using bovine serum albumin at the same concentration. (ii) Horses. Nine horses from one thoroughbred stud were used. These were all 2-year-old animals which had been given a course of commercial S. equi vaccine 15 months previously. The animals were kept together on the same property and were neither moved from the one paddock nor exposed to other horses after vaccination with the purified product from S. equi. A single dose of vaccine was given and consisted of 200 gg of alum-precipitated protein injected intramuscularly into the neck region.
Measurement of antibody response. (i) Rabbits. Serum was collected from the rabbits given three injections, on days 1, 15, 26, and 40, and from the animals given four injections, on days 1, 15, 26, 40, and 61. The serum antibody level during the course of immunization was measured by the bactericidal test (10) and the long-chain test (14) , and the protective capacity of the serum was measured by the mouse protection test (9) .
(ii) Horses. Prevaccination serum samples were obtained, and both those and the samples collected 9 days postvaccination were tested using the long-chain and bactericidal tests.
Bactericidal tests. The ability of antisera produced in rabbits vaccinated with the purified protein preparation to opsonize S. equi was measured using a modification of the bactericidal test. Test serum (0.04 ml), freshly drawn human heparinized blood (0.3 ml), and diluted S. equi rapidly multiplying (0.02 ml) were rotated in glass tubes at 37 C for 5 h. After incubation, 0.02 ml was removed, and pour plates were prepared. Counts were made after 36 h of incubation.
Long-chain tests. The ability of immune serum to induce long-chain formation in rapidly growing S. equi was tested. Tubes containing test serum (0.2 ml) and rapidly multiplying S. equi (0.05 ml of a 1: 100 [vol/vol ] dilution) were incubated at 37 C for 4 h. One loopful of the mixture was then placed on a glass slide, air-dried, heat-fixed, and stained with methylene blue.
Mouse protection tests. Mice weighing approximately 20 g were injected intraperitoneally with 0.5 ml of the serum to be tested. Twenty-two hours later, 0.5 ml of the challenge dose was given, also intraperitoneally. This latter injection consisted of a 4.5-to 5-h culture of S. equi appropriately diluted. Control mice were given normal rabbit serum. The tests were run for 10 days, after which surviving mice were discarded.
Absorption of serums. (i) Whole cells. Sera prepared against S. equi were absorbed either with the homologous organism or with a random mucoid strain of S. zooepidemicus of equine origin. The washed and heat-killed cells from 100 ml of an overnight culture were mixed with 1 ml of serum, incubated for 1 h at 37 C, and left overnight at 4 C.
(ii) Ethanol-concentrated extracts. Hot acid extracts prepared as above were concentrated by the addition of 4 vol of ethanol to 1 vol of the antigen extract. The precipitate was then taken up in 1 vol of serum, and absorption was performed as above.
INFECT. IMMUNITY fraction of S. equi is shown in Fig. 1 . It is to be noted that the protein was eluted as a sharp peak which appeared at around tube 9 after application of the 0.02 M HCl. The average yield of purified M-like protein from a 9-liter volume was around 10 mg.
Immunodiffusion analyses of the purified and partially purified products with unabsorbed antisera from animals immunized with heatkilled whole cells of S. equi are shown in Fig. 2 Table 3 . After the third injection, the serum of all seven rabbits was still strongly bactericidal and induced the formation of even longer streptococcal chains.
The rabbits immunized with a series of 10-,ug doses required four injections before satisfactory immune responses could be regularly obtained. Three injections appeared to be adequate as an antigenic stimulus in some rabbits and were sufficient to allow the fourth dose to produce serums strongly capable of opsonizing homologous organisms and of inducing formation of long chains in the other rabbits.
In the horses, prevaccination long-chain indexes and serum bactericidal capacities were at a level consistent with animals vaccinated 15 months previously (J. B. Woolcock, unpublished data). One dose of the purified protein product resulted in a sharp rise in the longchain index as well as conversion of the serum to become strongly opsonizing (Table 4) . No animal suffered any reaction to the injection.
When serum from one of the vaccinated rabbits was absorbed with whole cells of S. equi or with an ethanol-concentrated acid extract of that organism, the bactericidal capacity of that serum was eliminated (Table 5 ). Comparable absorption with S. zooepidemicus had no effect on the bactericidal capacity of the serum nor did whole S. equi cells or the ethanol-concentrated acid extract derived therefrom, when these cells were grown in broth containing 0.05% trypsin. This adds further support to the proposal that the product derived from S. equi by acid extraction and subsequently purified and used as a vaccine is indeed analogous to the M protein of group A streptococci. DISCUSSION This work both confirms the presence of an M-like protein in S. equi and indicates that such a product can be highly purified. Bazeley et al. (3) had suggested that this fraction existed in the S. equi cell, and this suggestion was supported by Moore and Bryans (13) . Both groups of workers used Lancefield extracts of the organism (hot acid extraction) and had 13.5 None .. 14.7 aLong-chain index = (mean chain length in antiserum)/(mean chain length in normal serum). b Hot acid extract followed by precipitation with ethanol was the precipitate used for absorption.
identified the protein by alcohol precipitation or trypsin lability. Whereas the first-named group separated this fraction, they presented no evidence to support their claim for its analogy with the M protein of group A streptococci. The present study, although not providing evidence along every avenue investigated with the group A streptococci, does give experimental support for the idea that such a cell wall protein component does exist in S. equi.
The results further demonstrate that S. equi possesses a cell wall protein which, in relatively small quantity, can act as a satisfactory antigen in evoking formation of protective antibodies. In its capacity to induce opsonizing antibodies, it exhibits the property with which the M protein of group A streptococci is associated in protecting against homologous challenge in humans and in experimental animals. That S. equi should have such a component is not surprising in view of the close similarity between the nature of S. equi infection in horses and group A infections in humans. Vaccination against the animal infection has been practiced for many years, and satisfactory immune responses have been obtained after multiple doses of large quantities of inactivated whole cells (5) . Nevertheless, the nature of the immunizing antigen has not heretofore been determined. This study suggests that S. equi is not unlike its group A counterparts in its possession of a cell wall protein component, antibodies against which are protective against infection.
Previous studies have indicated that S. equi is antigenically homogeneous (2, 13) . This has been assessed by mouse protection tests and antigenic typing. The latter method indicated the presence of trypsin-labile antigens in acid extracts of the organism. Such extracts contain not only these antigens, but others which can produce confusing serological cross-reactions. Crude extracts of group A streptococci also contain a multiplicity of antigens, and many of these behave similarly to M protein (16) . Some of the cross-reactions can still be obtained after purification by using such procedures as ethanol precipitation and ammonium sulphate fractionation. These difficulties have been experienced in the present studies on the M-like protein of S. equi. Crude extracts of S. equi reacted regularly with commercial antiserum raised against an unrelated group C streptococcus. The identity of this latter organism is uncertain, but it is almost without doubt not S. equi. Yet, acid extracts which had been partially purified by repeated ethanol precipitations still reacted with this serum. It was clear, therefore, that further purification was necessary before a VOL. 10, 1974 (7) . This data suggested that, to obtain a product from S. equi with equal purity and antigenic potency, similar procedures would be necessary. The results confirm this. Two doses of 100 ,ug each were adequate as antigenic stimuli, whereas four doses induced a similar immune response at the lower dosage (10 ,g). The responses thus obtained were equivalent to those resulting from a multiple series of injections of whole or mechanically disintegrated cells given over a 4-week period.
The value of the long-chain test as a measure of antibody in test serum has been established with group A streptococci. Its use in evaluation of anti-S. equi sera has not been established. There is a good correlation between bactericidal capacity and ability to induce long-chain formation (Table 2) . In tests such as this, the difficulty is to nominate the figure which will be used to indicate that a serum possesses immune capacity. With human sera, this figure (or long-chain index) is usually taken to be five (4) . In the present work, the same figure has been used, and it appears that this value is also applicable to equine serums (Woolcock, unpublished data).
Vaccination against S. equi infection in the horse has been carried out for many years in some countries, and effective vaccines consist of very young cultures which have been inactivated (1) . When older (24 h) cultures are used in the vaccine, satisfactory immune responses are not obtained. With the aid of fluorescent anti- bTMC, too many to count.
c Hot acid extract, followed by precipitation with ethanol was the precipitate used for absorption. body, it has been shown that group A streptococci may lose the M protein from their cell wall when the capsule is removed (8) . Since a 24-h culture of S. equi has virtually lost all of its capsular material, it is quite possible that these older cultures lose a considerable proportion of their M-like protein content, with concomitant decrease in immunizing potential.
The immediate needs with respect to development of S. equi vaccines in horses appear to be (i) fewer doses in the initial vaccination schedule and (ii) smaller doses of the vaccine. Predictions concerning the first suggestion cannot be offered on the basis of the data provided here. However, the second suggestion is a distinct possibility, following the anamnestic response after introduction of 200 gg into previously vaccinated animals. It is quite possible that the immunogenic fraction of S. equi can perform equally well without such extensive purification. However, the demonstration of the existence and antigenicity of this product of S. equi cells should indicate to those involved in the production and refinement of S. equi vaccines that efforts towards purification would be rewarded.
